Fernando Diaz Del Valle1, Jonathan K Zakrajsek1, Sung-Joon Min2, Patricia B Koff1, Harold W Bell1, Keegan A Kincaid1, Daniel N Frank3, Vijay Ramakrishnan4, Moumita Ghosh1, R William Vandivier5. 1. Division of Pulmonary Sciences and Critical Care Medicine, Colorado Pulmonary Outcomes Research Group (CPOR), Aurora, CO. 2. Division of Healthcare Policy and Research, University of Colorado Denver Anschutz Medical Campus, Aurora, CO. 3. Division of Infectious Diseases, Department of Medicine, University of Colorado Denver Anschutz Medical Campus, Aurora, CO. 4. Department of Otolaryngology-Head and Neck Surgery, University of Colorado Denver Anschutz Medical Campus, Aurora, CO. 5. Division of Pulmonary Sciences and Critical Care Medicine, Colorado Pulmonary Outcomes Research Group (CPOR), Aurora, CO. Electronic address: bill.vandivier@cuanschutz.edu.
Abstract
BACKGROUND: Twenty-five percent to 45% of COPD is caused by exposures other than active smoking. Secondhand tobacco smoke (SHS) has been suggested as an independent cause of COPD, based on its association with increased respiratory symptoms and a small decrease in lung function, but its impact on respiratory health and lung function after exposure cessation has not been explored. RESEARCH QUESTION: What are the consequences of airline SHS exposure on respiratory health and lung function decades after cessation? STUDY DESIGN AND METHODS: We performed a cohort study involving flight attendants because of their exposure to SHS that stopped > 20 years ago. We included subjects ≥ 50 years of age with > 1 year vs ≤ 1 year of airline SHS exposure (ie, exposed vs unexposed). Respiratory quality of life, as determined by the St. George's Respiratory Questionnaire (SGRQ), was the primary outcome for respiratory health. Key secondary outcomes included general quality of life (the Rand Corporation modification of the 36-item Short Form Health Survey Questionnaire; RAND-36), respiratory symptoms (COPD Assessment Test; CAT), and spirometry. RESULTS: The study enrolled 183 SHS-exposed and 59 unexposed subjects. Exposed subjects were 66.7 years of age, and 90.7% were female. They were hired at 23.8 years of age, were exposed to airline SHS for 16.1 years, and stopped exposure 27.5 years before enrollment. Prior SHS exposure was associated with worsened SGRQ (6.7 units; 95% CI, 2.7-10.7; P = .001), RAND-36 physical and social function, and CAT vs unexposed subjects. SHS exposure did not affect prebronchodilator spirometry or obstruction, but was associated with lower postbronchodilator FEV1 and FEV1/FVC, total lung capacity, and diffusing capacity of the lungs for carbon monoxide in a subset of subjects. Former smoking and SHS exposure synergistically worsened SGRQ (β = 8.4; 95% CI, 0.4-16.4; P = .04). SHS exposure in people who never smoked replicated primary results and was associated with worsened SGRQ vs unexposed people (4.7 units; 95% CI, 0.7-7.0; P = .006). INTERPRETATION: Almost three decades after exposure ended, airline SHS exposure is strongly and dose-dependently associated with worsened respiratory health, but less robustly associated with airflow abnormalities used to diagnose COPD.
BACKGROUND: Twenty-five percent to 45% of COPD is caused by exposures other than active smoking. Secondhand tobacco smoke (SHS) has been suggested as an independent cause of COPD, based on its association with increased respiratory symptoms and a small decrease in lung function, but its impact on respiratory health and lung function after exposure cessation has not been explored. RESEARCH QUESTION: What are the consequences of airline SHS exposure on respiratory health and lung function decades after cessation? STUDY DESIGN AND METHODS: We performed a cohort study involving flight attendants because of their exposure to SHS that stopped > 20 years ago. We included subjects ≥ 50 years of age with > 1 year vs ≤ 1 year of airline SHS exposure (ie, exposed vs unexposed). Respiratory quality of life, as determined by the St. George's Respiratory Questionnaire (SGRQ), was the primary outcome for respiratory health. Key secondary outcomes included general quality of life (the Rand Corporation modification of the 36-item Short Form Health Survey Questionnaire; RAND-36), respiratory symptoms (COPD Assessment Test; CAT), and spirometry. RESULTS: The study enrolled 183 SHS-exposed and 59 unexposed subjects. Exposed subjects were 66.7 years of age, and 90.7% were female. They were hired at 23.8 years of age, were exposed to airline SHS for 16.1 years, and stopped exposure 27.5 years before enrollment. Prior SHS exposure was associated with worsened SGRQ (6.7 units; 95% CI, 2.7-10.7; P = .001), RAND-36 physical and social function, and CAT vs unexposed subjects. SHS exposure did not affect prebronchodilator spirometry or obstruction, but was associated with lower postbronchodilator FEV1 and FEV1/FVC, total lung capacity, and diffusing capacity of the lungs for carbon monoxide in a subset of subjects. Former smoking and SHS exposure synergistically worsened SGRQ (β = 8.4; 95% CI, 0.4-16.4; P = .04). SHS exposure in people who never smoked replicated primary results and was associated with worsened SGRQ vs unexposed people (4.7 units; 95% CI, 0.7-7.0; P = .006). INTERPRETATION: Almost three decades after exposure ended, airline SHS exposure is strongly and dose-dependently associated with worsened respiratory health, but less robustly associated with airflow abnormalities used to diagnose COPD.
Authors: D E Abbey; R J Burchette; S F Knutsen; W F McDonnell; M D Lebowitz; P L Enright Journal: Am J Respir Crit Care Med Date: 1998-07 Impact factor: 21.405
Authors: Jonathan D Klein; Margaret E Chamberlin; Elizabeth A Kress; Mark W Geraci; Susan Rosenblatt; Rachel Boykan; Brian Jenssen; Stanley M Rosenblatt; Sharon Milberger; William G Adams; Adam O Goldstein; Nancy A Rigotti; Melbourne F Hovell; Amanda L Holm; Richard W Vandivier; Thomas L Croxton; Patricia L Young; Lani Blissard; Kate Jewell; Leisa Richardson; John Ostrow; Elissa A Resnick Journal: Nicotine Tob Res Date: 2019-08-13 Impact factor: 4.244
Authors: M Nebot; M J López; G Gorini; M Neuberger; S Axelsson; M Pilali; C Fonseca; K Abdennbi; A Hackshaw; H Moshammer; A M Laurent; J Salles; M Georgouli; M C Fondelli; E Serrahima; F Centrich; S K Hammond Journal: Tob Control Date: 2005-02 Impact factor: 7.552
Authors: Pierre-Olivier Bridevaux; Jacques Cornuz; Jean-Michel Gaspoz; Bernard Burnand; Ursula Ackermann-Liebrich; Christian Schindler; Philippe Leuenberger; Thierry Rochat; Margaret W Gerbase Journal: Arch Intern Med Date: 2007-12-10
Authors: Ana Navas-Acien; Armando Peruga; Patrick Breysse; Alfonso Zavaleta; Adriana Blanco-Marquizo; Raul Pitarque; Marisol Acuña; Katya Jiménez-Reyes; Vera L Colombo; Graciela Gamarra; Frances A Stillman; Jonathan Samet Journal: JAMA Date: 2004-06-09 Impact factor: 56.272
Authors: Eileen McNeely; Sara Gale; Ira Tager; Laurel Kincl; Julie Bradley; Brent Coull; Steve Hecker Journal: Environ Health Date: 2014-03-10 Impact factor: 5.984
Authors: Anne G Wheaton; Yong Liu; Janet B Croft; Brenna VanFrank; Thomas L Croxton; Antonello Punturieri; Lisa Postow; Kurt J Greenlund Journal: MMWR Morb Mortal Wkly Rep Date: 2019-06-21 Impact factor: 17.586
Authors: Mehrdad Arjomandi; Siyang Zeng; Jeroen Geerts; Rachel K Stiner; Bruce Bos; Ian van Koeverden; Jason Keene; Brett Elicker; Paul D Blanc; Warren M Gold Journal: BMJ Open Respir Res Date: 2018-05-05